BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial

BACKGROUND. Bacillus Calmette-Guérin (BCG) vaccine is administered at birth to protect infants against tuberculosis throughout Africa, where most perinatal HIV-1 transmission occurs. We examined whether BCG vaccination alters the levels of activated HIV target T cells in HIV-exposed South African in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCI Insight
Main Authors: Gasper, Melanie A., Hesseling, Anneke C., Mohar, Isaac, Myer, Landon, Azenkot, Tali, Passmore, Jo-Ann S., Hanekom, Willem, Cotton, Mark F., Crispe, I. Nicholas, Sodora, Donald L., Jaspan, Heather B.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2017
Assuntos:
Clinical Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5374072/
https://ncbi.nlm.nih.gov/pubmed/28405623
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.91963
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados